Product Images Ketorolac Tromethamine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Ketorolac Tromethamine NDC 51662-1669 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - 0409 3796 25 Ketorolac Tromethamine Vial Image
Table - 51662 1669 Table 1
Table - 51662 1669 Table 3
This text provides a list of gastrointestinal experiences and other potential side effects associated with a certain condition or medication. The gastrointestinal symptoms mentioned include abdominal pain, constipation, diarrhea, dyspepsia, flatulence, fullness, ulcers, gross bleeding, perforation, heartburn, nausea, stomatitis, and vomiting. Additionally, other experiences listed involve abnormal renal function, anemia, dizziness, drowsiness, eczema, elevated liver enzymes, headaches, hypertension, increased bleeding time, injection site pain, pruritus, purpura, rashes, tinnitus, and sweating. The overall incidence of these side effects is reported to be greater than 10%.*
structure - 51662 1669 structure
This text describes a chemical reaction involving compounds with the formulas C15H13NO3 and C8H11NO2. It also includes a figure labeled as "FIGURE 1" with a chemical equation showing the conversion of one compound to another.*
Table - 51662 1669 table 2
Table - 51662 1669 table 4
This is a table displaying the incidence of clinically serious bleeding in relation to age, total daily dose, and history of gastrointestinal bleeding after up to 5 days of treatment with Ketorolac Tromethamine Injection. The data is divided into two sections: one for adult patients without a history of gastrointestinal issues and another for adult patients with a history of gastrointestinal bleeding. The table provides percentages of bleeding incidents based on different age groups and total daily doses of the medication.*
Label - 51662 1669 1 Vial label
This text contains a series of identification numbers or codes, a mention of the manufacturer's insert, and information about the distributor HF Acquisition Co., LLC located in Mukilteo, WA 58275. It also mentions that the content is for prescription (Rx) use only.*
Label - 51662 1669 2 pouch label
This text provides information on Ketorolac Tromethamine injection, USP in a 60mg/2mL vial. The medication is for intramuscular use only and each mL contains 30mg of Ketorolac Tromethamine, along with 10% alcohol and 4.35mg of sodium chloride. The pH is adjusted to 7.4 and the vial should be discarded after use. The expiration date is 2023-89-19 and the lot number is 789218. The manufacturer's original NDC is 0409-3796-25. Recommended dosage and other prescribing information can be found in the package insert. The product should be stored at controlled room temperature. Distributed by HF Acgursitien e, LEC in Mukilteo, WA 98275.*
Label - 51662 1669 3 box label
This text is a detailed description of Ketorolac Tromethamine injection, USP. It provides information on the dosage strength, vial size, NDC number, lot number, and expiration date. Additionally, the text offers instructions for use, storage conditions, and the manufacturer's details. The medication is intended for intramuscular use only, with each mL containing 30mg of Ketorolac Tromethamine. Users are advised to discard any unused portions. The text also mentions the presence of alcohol, sodium chloride, and possible pH-adjusting agents in the solution. Overall, this description provides essential details for the proper use and handling of the Ketorolac Tromethamine injection.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
